GERI-BP002-A

GERI-BP002-A is an inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT) produced by Aspergillus fumigatus F93, which can be used in cancer research[1].

Product Specifications

CAS Number

[119-47-1]

UNSPSC

12352005

Hazard Statement

H360

Target

Acyltransferase

Type

Natural Products

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/geri-bp002-a.html

Concentration

10mM

Purity

99.77

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

OC1=C(C(C)(C)C)C=C(C)C=C1CC2=CC(C)=CC(C(C)(C)C)=C2O

Molecular Formula

C23H32O2

Molecular Weight

340.50

Precautions

H360

References & Citations

[1]Kim Y K, et al. GERI-BP002-A, novel inhibitor of acyl-CoA: cholesterol acyltransferase produced by Aspergillus fumigatus F93[J]. The Journal of Antibiotics, 1996, 49 (1) : 31-36.